epirubicin has been researched along with Amenorrhea in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, CH; Rozita, AM; Taib, NA; Tiong, V; Yip, CH | 1 |
| Barni, S; Benasso, M; Bighin, C; Bisagni, G; Bruzzi, P; Cavazzini, G; Ceppi, M; Cognetti, F; De Censi, A; De Laurentiis, M; De Placido, S; Del Mastro, L; Durando, A; Giraudi, S; Lambertini, M; Levaggi, A; Michelotti, A; Montemurro, F; Puglisi, F; Scotto, T; Turletti, A; Valle, E | 1 |
| Coleman, RE; El-Helw, LM; Hatton, MQ; Purohit, OP; Zekri, JM | 1 |
| Aebi, S; Basser, RL; Cinieri, S; Coates, AS; Colleoni, M; Gelber, RD; Goldhirsch, A; Green, MD; Martinelli, G; Peccatori, F; Price, KN; Sun, Z; Viale, G | 1 |
| Ahlgren, J; Andersen, J; Andersson, M; Bergh, J; Bjerre, K; Blomquist, C; Lidbrink, E; Lindman, H; Mouridsen, H; Rosendahl, M | 1 |
| Chen, L; Dai, JC; Ling, LJ; Liu, XA; Ma, JJ; Tao, AD; Wang, S; Yin, H; Zha, XM; Zhou, WB | 1 |
| Carter, WB; Cox, CE; Gross-King, M; Ismail-Khan, R; Lacevic, M; Minton, SE; Moore, AP; Munster, PN; Xu, P | 1 |
| Ding, Q; He, Z; Liang, X; Liu, X; Wang, S; Zha, X; Zhou, W | 1 |
| Bramwell, V; Day, AG; Levine, M; Ottaway, JA; Parulekar, WR; Pritchard, KI; Shepherd, LE; Trudeau, ME | 1 |
| Aebi, S; Basser, RL; Castiglione-Gertsch, M; Cinieri, S; Coates, AS; Gelber, RD; Goldhirsch, A; Green, MD; Martinelli, G; O'Neill, A; Peccatori, F; Price, KN; Viale, G | 1 |
| Bonneterre, J; Chollet, P; Clavère, P; Fargeot, P; Fumoleau, P; Goudier, MJ; Guastalla, JP; Kerbrat, P; Monnier, A; Roché, H; Serin, D | 1 |
| Berliere, M; Dalenc, F; Donnez, J; Kerger, J; Machiels, JP; Malingret, N; Piette, P; Roche, H; Symann, M; Vindevogel, A | 1 |
6 trial(s) available for epirubicin and Amenorrhea
| Article | Year |
|---|---|
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Premenopause; Survival Analysis | 2017 |
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Recombinant Proteins; Stem Cell Transplantation; Survival Rate; Tamoxifen; Treatment Outcome | 2009 |
The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study.
Topics: Adult; Age Distribution; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Leukocyte Count; Leukopenia; Menstrual Cycle; Middle Aged; Primary Ovarian Insufficiency | 2009 |
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fertility; Fluorouracil; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Inhibins; Menstruation; Neoadjuvant Therapy; Neoplasm Staging; Ovary; Paclitaxel; Tamoxifen; Time Factors; Treatment Outcome; Triptorelin Pamoate | 2012 |
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
Topics: Adult; Aged; Amenorrhea; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Odds Ratio; Recombinant Proteins; Risk Assessment; Risk Factors; Stem Cells; Survival Analysis; Treatment Outcome | 2006 |
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Estrogen Antagonists; Female; Fluorouracil; Gonadotropin-Releasing Hormone; Heart Diseases; Humans; Lymph Node Excision; Middle Aged; Neoplasms; Premenopause; Receptors, Steroid; Tamoxifen; Triptorelin Pamoate | 2006 |
6 other study(ies) available for epirubicin and Amenorrhea
| Article | Year |
|---|---|
Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asia; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Incidence; Induction Chemotherapy; Menstruation; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Retrospective Studies; Tamoxifen; Taxoids; Young Adult | 2014 |
Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Fertility; Humans; Medical Records; Middle Aged; Retrospective Studies; Vinblastine; Vinorelbine | 2008 |
Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fertility; Fluorouracil; Humans; Incidence; Logistic Models; Middle Aged; Odds Ratio; Retrospective Studies; Risk Assessment; Risk Factors; Tamoxifen; Taxoids; Time Factors; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2010 |
The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; China; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Premenopause; Retrospective Studies; Taxoids | 2012 |
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Incidence; Methotrexate; Middle Aged; Premenopause; Prognosis; Retrospective Studies; Risk Factors | 2005 |
Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.
Topics: Adult; Amenorrhea; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Incidence; Middle Aged; Retrospective Studies; Taxoids | 2008 |